AGREEMENT AND PLAN OF MERGER by and among: Sorrento Therapeutics, Inc., a Delaware corporation; SP Merger Sub, Inc., a Delaware corporation; SmartPharm Therapeutics, Inc., a Delaware corporation; and John C. Thomas, Jr., as the Stockholders’...Merger Agreement • August 20th, 2020 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
This Agreement and Plan of Merger is made and entered into as of August 20, 2020, by and among Sorrento Therapeutics, Inc., a Delaware corporation (“Parent”); SP Merger Sub, Inc., a Delaware corporation (“Merger Sub”); SmartPharm Therapeutics, Inc., a Delaware corporation (the “Company”); and John C. Thomas, Jr. (the “Stockholders’ Representative”), as representative of the Stockholders. Certain other capitalized terms used in this Agreement are defined in Exhibit A.
